Lido Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.5M | Sell |
126,022
-11,679
| -8% | -$1.25M | 0.05% | 198 |
|
2025
Q1 | $13.9M | Buy |
137,701
+2,954
| +2% | +$298K | 0.06% | 184 |
|
2024
Q4 | $12M | Buy |
134,747
+13,018
| +11% | +$1.16M | 0.05% | 188 |
|
2024
Q3 | $10.2M | Buy |
121,729
+4,394
| +4% | +$368K | 0.05% | 186 |
|
2024
Q2 | $9.04M | Buy |
117,335
+101,587
| +645% | +$7.82M | 0.05% | 183 |
|
2024
Q1 | $1.08M | Buy |
15,748
+391
| +3% | +$26.8K | 0.01% | 574 |
|
2023
Q4 | $888K | Buy |
15,357
+2,091
| +16% | +$121K | 0.01% | 601 |
|
2023
Q3 | $700K | Buy |
13,266
+3,669
| +38% | +$194K | 0.01% | 585 |
|
2023
Q2 | $519K | Buy |
9,597
+2,519
| +36% | +$136K | ﹤0.01% | 654 |
|
2023
Q1 | $354K | Sell |
7,078
-2,398
| -25% | -$120K | ﹤0.01% | 748 |
|
2022
Q4 | $438K | Buy |
9,476
+83
| +0.9% | +$3.84K | 0.01% | 571 |
|
2022
Q3 | $363K | Buy |
9,393
+218
| +2% | +$8.43K | ﹤0.01% | 581 |
|
2022
Q2 | $341K | Sell |
9,175
-154
| -2% | -$5.72K | ﹤0.01% | 590 |
|
2022
Q1 | $413K | Buy |
9,329
+2,235
| +32% | +$98.9K | ﹤0.01% | 588 |
|
2021
Q4 | $301K | Buy |
7,094
+227
| +3% | +$9.63K | ﹤0.01% | 710 |
|
2021
Q3 | $297K | Buy |
6,867
+509
| +8% | +$22K | ﹤0.01% | 655 |
|
2021
Q2 | $272K | Buy |
6,358
+798
| +14% | +$34.1K | ﹤0.01% | 652 |
|
2021
Q1 | $215K | Sell |
5,560
-12
| -0.2% | -$464 | ﹤0.01% | 689 |
|
2020
Q4 | $200K | Sell |
5,572
-2,866
| -34% | -$103K | ﹤0.01% | 678 |
|
2020
Q3 | $322K | Buy |
8,438
+47
| +0.6% | +$1.79K | 0.01% | 409 |
|
2020
Q2 | $295K | Buy |
8,391
+1,976
| +31% | +$69.5K | 0.01% | 393 |
|
2020
Q1 | $209K | Buy |
6,415
+227
| +4% | +$7.4K | 0.01% | 446 |
|
2019
Q4 | $280K | Buy |
6,188
+522
| +9% | +$23.6K | 0.01% | 466 |
|
2019
Q3 | $231K | Sell |
5,666
-839
| -13% | -$34.2K | 0.01% | 461 |
|
2019
Q2 | $279K | Buy |
+6,505
| New | +$279K | 0.02% | 400 |
|